Investment analysts at KeyCorp started coverage on shares of Vylor (NYSE:VYLR – Get Free Report) in a report issued on Tuesday, Marketbeat.com reports. The firm set a “hold” rating on the stock.
VYLR has been the subject of a number of other research reports. BMO Capital Markets began coverage on shares of Vylor in a research report on Friday, October 2nd. They set an “outperform” rating and a $85.00 price objective for the company. Oppenheimer began coverage on Vylor in a research report on Tuesday. They set an “outperform” rating and a $82.00 target price on the stock. Zacks Research raised Vylor to a “hold” rating in a report on Monday. Vertical Research began coverage on Vylor in a research report on Monday. They issued a “buy” rating and a $74.00 price target for the company. Finally, Wolfe Research raised Vylor to a “strong-buy” rating in a research report on Thursday, October 1st. Two investment analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $82.00.
View Our Latest Report on Vylor
Vylor Price Performance
About Vylor
Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.
Recommended Stories
- Five stocks we like better than Vylor
- Skydance Just Became a Media Giant—With an $80 Billion Debt Load
- Could Velo3D Be the Next Defense Buyout Target?
- Penguin Solutions Is Soaring as AI Memory Demand Explodes
- Alphabet’s Chart Is Coiling—and the Fundamentals May Be Ready to Back It Up
Receive News & Ratings for Vylor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vylor and related companies with MarketBeat.com's FREE daily email newsletter.
